EP2397122 - Formulations of neramexane dosage forms [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 20.03.2015 Database last updated on 24.08.2024 | Most recent event Tooltip | 15.07.2016 | Lapse of the patent in a contracting state New state(s): LU, TR | published on 17.08.2016 [2016/33] | Applicant(s) | For all designated states Merz Pharma GmbH & Co. KGaA Eckenheimer Landstrasse 100 60318 Frankfurt / DE | [2011/51] | Inventor(s) | 01 /
Seiller, Erhard Mozartstrasse 12a 61130 Nidderau / DE | 02 /
Hauptmeier, Bernhard Neue Weinbergstrasse 10 63571 Gelnhausen / DE | 03 /
Yang, Yan 60 George Street Roslyn Heights New York 11577 / US | 04 /
Janjikhel, Rajiv 58 Sunflower Ridge Road South Setauket New York 11720 / US | 05 /
Rao, Niranjan 88 Ketcham Road Belle Mead, NJ 08502 / US | 06 /
Periclou, Antonia 89 Beckwith Place Rutherford, NJ 07070 / US | 07 /
Abramowitz, Wattanporn 4 Abbington Lane West Windsor, NJ 08550 / US | 08 /
Dedhiya, Mahendra G. 1 Lea Court Pomona New York 10970 / US | [2012/19] |
Former [2012/03] | 01 /
Seiller, Erhard Mozartstrasse 12a 61130 Nidderau / DE | ||
02 /
Hauptmeier, Bernhard Neue Weinbergstrasse 10 63571 Gelnhausen / DE | |||
03 /
Yang, Yan 60 George Street Roslyn Heights New York 11577 / US | |||
04 /
Janjikhel, Rajiv 58 Sunflower Ridge Road South Setauket New York 11720 / US | |||
05 /
Rao, Niranjan 88 Ketcham Road Belle Mead, NJ 08502 / US | |||
06 /
Periclou, Antonia 31 River Court, Apt. 101 Jersey City, New Jersey 07310 / US | |||
07 /
Abramowitz, Wattanporn 4 Abbington Lane West Windsor, NJ 08550 / US | |||
08 /
Dedhiya, Mahendra G. 1 Lea Court Pomona New York 10970 / US | Representative(s) | Goddard, Christopher Robert Dehns St Bride's House 10 Salisbury Square London EC4Y 8JD / GB | [2014/20] |
Former [2011/51] | Goddard, Christopher Robert Dehns St Bride's House 10 Salisbury Square London EC4Y 8JD / GB | Application number, filing date | 11179637.1 | 16.06.2005 | [2011/51] | Priority number, date | US20040581244P | 17.06.2004 Original published format: US 581244 P | [2011/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2397122 | Date: | 21.12.2011 | Language: | EN | [2011/51] | Type: | A3 Search report | No.: | EP2397122 | Date: | 25.01.2012 | Language: | EN | [2012/04] | Type: | B1 Patent specification | No.: | EP2397122 | Date: | 14.05.2014 | Language: | EN | [2014/20] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 22.12.2011 | Classification | IPC: | A61K9/20, A61K31/13 | [2011/51] | CPC: |
A61K9/0095 (EP);
A61K31/13 (EP,KR);
A61K31/40 (EP);
A61K9/20 (KR);
A61K9/2013 (EP);
A61K9/2054 (EP);
A61K9/2095 (EP);
A61K9/28 (KR);
A61P25/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2011/51] | Extension states | AL | 25.07.2012 | BA | 25.07.2012 | HR | 25.07.2012 | LV | 25.07.2012 | MK | 25.07.2012 | YU | 25.07.2012 | Title | German: | Formulierungen aus Neramexan-Dosierformen | [2011/51] | English: | Formulations of neramexane dosage forms | [2011/51] | French: | Formulations de formes pharmaceutiques de néramexane | [2011/51] | Examination procedure | 25.07.2012 | Amendment by applicant (claims and/or description) | 25.07.2012 | Examination requested [2012/36] | 31.01.2013 | Despatch of a communication from the examining division (Time limit: M04) | 10.06.2013 | Reply to a communication from the examining division | 28.11.2013 | Communication of intention to grant the patent | 28.03.2014 | Fee for grant paid | 28.03.2014 | Fee for publishing/printing paid | 07.04.2014 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP05857458.3 / EP1765287 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050857458) is 24.01.2011 | Opposition(s) | 17.02.2015 | No opposition filed within time limit [2015/17] | Fees paid | Renewal fee | 31.08.2011 | Renewal fee patent year 03 | 31.08.2011 | Renewal fee patent year 04 | 31.08.2011 | Renewal fee patent year 05 | 31.08.2011 | Renewal fee patent year 06 | 31.08.2011 | Renewal fee patent year 07 | 31.03.2012 | Renewal fee patent year 08 | 10.06.2013 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 16.06.2005 | AT | 14.05.2014 | BE | 14.05.2014 | BG | 14.05.2014 | CY | 14.05.2014 | CZ | 14.05.2014 | DK | 14.05.2014 | EE | 14.05.2014 | FI | 14.05.2014 | LT | 14.05.2014 | MC | 14.05.2014 | NL | 14.05.2014 | PL | 14.05.2014 | RO | 14.05.2014 | SE | 14.05.2014 | SI | 14.05.2014 | SK | 14.05.2014 | TR | 14.05.2014 | IE | 16.06.2014 | LU | 16.06.2014 | CH | 30.06.2014 | LI | 30.06.2014 | GR | 15.08.2014 | IS | 14.09.2014 | PT | 15.09.2014 | [2016/33] |
Former [2016/32] | HU | 16.06.2005 | |
AT | 14.05.2014 | ||
BE | 14.05.2014 | ||
BG | 14.05.2014 | ||
CY | 14.05.2014 | ||
CZ | 14.05.2014 | ||
DK | 14.05.2014 | ||
EE | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
MC | 14.05.2014 | ||
NL | 14.05.2014 | ||
PL | 14.05.2014 | ||
RO | 14.05.2014 | ||
SE | 14.05.2014 | ||
SI | 14.05.2014 | ||
SK | 14.05.2014 | ||
IE | 16.06.2014 | ||
CH | 30.06.2014 | ||
LI | 30.06.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
PT | 15.09.2014 | ||
Former [2016/25] | AT | 14.05.2014 | |
BE | 14.05.2014 | ||
BG | 14.05.2014 | ||
CY | 14.05.2014 | ||
CZ | 14.05.2014 | ||
DK | 14.05.2014 | ||
EE | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
MC | 14.05.2014 | ||
NL | 14.05.2014 | ||
PL | 14.05.2014 | ||
RO | 14.05.2014 | ||
SE | 14.05.2014 | ||
SI | 14.05.2014 | ||
SK | 14.05.2014 | ||
IE | 16.06.2014 | ||
CH | 30.06.2014 | ||
LI | 30.06.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
PT | 15.09.2014 | ||
Former [2016/21] | AT | 14.05.2014 | |
BE | 14.05.2014 | ||
CY | 14.05.2014 | ||
CZ | 14.05.2014 | ||
DK | 14.05.2014 | ||
EE | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
MC | 14.05.2014 | ||
NL | 14.05.2014 | ||
PL | 14.05.2014 | ||
RO | 14.05.2014 | ||
SE | 14.05.2014 | ||
SI | 14.05.2014 | ||
SK | 14.05.2014 | ||
IE | 16.06.2014 | ||
CH | 30.06.2014 | ||
LI | 30.06.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
PT | 15.09.2014 | ||
Former [2015/36] | AT | 14.05.2014 | |
BE | 14.05.2014 | ||
CY | 14.05.2014 | ||
CZ | 14.05.2014 | ||
DK | 14.05.2014 | ||
EE | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
NL | 14.05.2014 | ||
PL | 14.05.2014 | ||
RO | 14.05.2014 | ||
SE | 14.05.2014 | ||
SI | 14.05.2014 | ||
SK | 14.05.2014 | ||
IE | 16.06.2014 | ||
CH | 30.06.2014 | ||
LI | 30.06.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
PT | 15.09.2014 | ||
Former [2015/21] | AT | 14.05.2014 | |
BE | 14.05.2014 | ||
CY | 14.05.2014 | ||
CZ | 14.05.2014 | ||
DK | 14.05.2014 | ||
EE | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
NL | 14.05.2014 | ||
PL | 14.05.2014 | ||
RO | 14.05.2014 | ||
SE | 14.05.2014 | ||
SK | 14.05.2014 | ||
IE | 16.06.2014 | ||
CH | 30.06.2014 | ||
LI | 30.06.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
PT | 15.09.2014 | ||
Former [2015/20] | AT | 14.05.2014 | |
BE | 14.05.2014 | ||
CY | 14.05.2014 | ||
CZ | 14.05.2014 | ||
DK | 14.05.2014 | ||
EE | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
NL | 14.05.2014 | ||
PL | 14.05.2014 | ||
RO | 14.05.2014 | ||
SE | 14.05.2014 | ||
SK | 14.05.2014 | ||
CH | 30.06.2014 | ||
LI | 30.06.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
PT | 15.09.2014 | ||
Former [2015/12] | AT | 14.05.2014 | |
BE | 14.05.2014 | ||
CY | 14.05.2014 | ||
CZ | 14.05.2014 | ||
DK | 14.05.2014 | ||
EE | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
NL | 14.05.2014 | ||
PL | 14.05.2014 | ||
RO | 14.05.2014 | ||
SE | 14.05.2014 | ||
SK | 14.05.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
PT | 15.09.2014 | ||
Former [2015/11] | AT | 14.05.2014 | |
BE | 14.05.2014 | ||
CY | 14.05.2014 | ||
CZ | 14.05.2014 | ||
DK | 14.05.2014 | ||
EE | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
PL | 14.05.2014 | ||
RO | 14.05.2014 | ||
SE | 14.05.2014 | ||
SK | 14.05.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
PT | 15.09.2014 | ||
Former [2015/10] | AT | 14.05.2014 | |
BE | 14.05.2014 | ||
CY | 14.05.2014 | ||
CZ | 14.05.2014 | ||
DK | 14.05.2014 | ||
EE | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
PL | 14.05.2014 | ||
SE | 14.05.2014 | ||
SK | 14.05.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
PT | 15.09.2014 | ||
Former [2015/08] | AT | 14.05.2014 | |
BE | 14.05.2014 | ||
CY | 14.05.2014 | ||
DK | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
PL | 14.05.2014 | ||
SE | 14.05.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
PT | 15.09.2014 | ||
Former [2015/02] | AT | 14.05.2014 | |
CY | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
PL | 14.05.2014 | ||
SE | 14.05.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
PT | 15.09.2014 | ||
Former [2014/51] | AT | 14.05.2014 | |
CY | 14.05.2014 | ||
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
PL | 14.05.2014 | ||
SE | 14.05.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
Former [2014/50] | CY | 14.05.2014 | |
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
PL | 14.05.2014 | ||
SE | 14.05.2014 | ||
GR | 15.08.2014 | ||
IS | 14.09.2014 | ||
Former [2014/49] | CY | 14.05.2014 | |
FI | 14.05.2014 | ||
LT | 14.05.2014 | ||
IS | 14.09.2014 | ||
Former [2014/48] | CY | 14.05.2014 | |
LT | 14.05.2014 | ||
Former [2014/47] | CY | 14.05.2014 | Documents cited: | Search | [IY]US6034134 (GOLD MARKUS [DE], et al) [I] 1-15 * column 1, lines 10-16 * * column 20, lines 45-49 * * column 21, lines 1-15 * * column 35, lines 33,39-44 * * column 5, line 10; claim 5 * * the whole document * [Y] 1-15; | [IY]US2003166634 (HENRICH MARKUS [DE], et al) [I] 1-15 * claim 4 * * paragraphs [0298] , [0303] * * paragraph [0006] * * paragraph [0344] * [Y] 1-15; | [AP]WO2005044228 (MERZ PHARMA GMBH & CO KGAA [DE], et al) [AP] 1-15 * the whole document * * example - ** claim - * | by applicant | US4122193 | US4273774 | US5061703 | US5234956 | US5334618 | US5382601 | US5455279 | US5506231 | US5614560 | US6034134 | US6071966 | US6194000 | US6413556 | US6444702 | US6479553 | US2003166634 | US2004034055 | - "Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations", CDER, FOOD AND DRUG ADMINISTRATION, (199709), page 17 | - NEUROPHARMACOLOGY, (199906), vol. 38, no. 6, pages 735 - 767 | - Pharmaceutical Dosage Forms: Tablets, MARCEL DEKKER, INC., (1982), vol. 3, pages 101 - 272 |